» Articles » PMID: 1705993

Equine Infectious Anemia Virus and Human Immunodeficiency Virus DNA Synthesis in Vitro: Characterization of the Endogenous Reverse Transcriptase Reaction

Overview
Journal J Virol
Date 1991 Apr 1
PMID 1705993
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The endogenous reverse transcriptase reaction of equine infectious anemia virus (EIAV) has been studied, and conditions allowing synthesis of full-length minus-strand DNA have been determined. In contrast to results reported for other retroviruses, synthesis of EIAV full-length minus-strand DNA was not impaired by high concentrations of Nonidet P-40, a nonionic detergent used to make the virion envelope permeable. All components of the reaction were titrated for maximum synthesis of complete minus strands, and a time course under the standardized conditions was determined. Minor subgenomic bands were observed in some cases, and both the size and proportion varied with reaction conditions. Conditions established for full-length EIAV DNA synthesis also allowed full-genome-length human immunodeficiency virus type 1 DNA synthesis. The human immunodeficiency virus type 1 DNA product contained a greater proportion of reverse transcripts that were shorter than the complete virus genome. Also in contrast to EIAV, the endogenous synthesis of high-molecular-weight human immunodeficiency virus type 1 DNA was drastically reduced at Nonidet P-40 concentrations above 0.02%. These results indicated that a detergent-stable core is not a property shared by all lentiviruses. The EIAV virion synthetic machinery is unusually stable and provides a convenient system for further in vitro study of reverse transcription.

Citing Articles

The Host Cell Metabolite Inositol Hexakisphosphate Promotes Efficient Endogenous HIV-1 Reverse Transcription by Stabilizing the Viral Capsid.

Jennings J, Shi J, Varadarajan J, Jamieson P, Aiken C mBio. 2020; 11(6).

PMID: 33262260 PMC: 7733946. DOI: 10.1128/mBio.02820-20.


Genomic flexibility of human endogenous retrovirus type K.

Dube D, Contreras-Galindo R, He S, King S, Gonzalez-Hernandez M, Gitlin S J Virol. 2014; 88(17):9673-82.

PMID: 24920813 PMC: 4136327. DOI: 10.1128/JVI.01147-14.


Implications of the nucleocapsid and the microenvironment in retroviral reverse transcription.

Mougel M, Cimarelli A, Darlix J Viruses. 2011; 2(4):939-960.

PMID: 21994662 PMC: 3185662. DOI: 10.3390/v2040939.


Revisiting HIV-1 uncoating.

Arhel N Retrovirology. 2010; 7:96.

PMID: 21083892 PMC: 2998454. DOI: 10.1186/1742-4690-7-96.


Strand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitro.

Warrilow D, Warren K, Harrich D PLoS One. 2010; 5(10):e13229.

PMID: 20949087 PMC: 2950853. DOI: 10.1371/journal.pone.0013229.


References
1.
Whetter L, Archambault D, Perry S, Gazit A, COGGINS L, Yaniv A . Equine infectious anemia virus derived from a molecular clone persistently infects horses. J Virol. 1990; 64(12):5750-6. PMC: 248720. DOI: 10.1128/JVI.64.12.5750-5756.1990. View

2.
Scolnick E, Rands E, Aaronson S, Todaro G . RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements. Proc Natl Acad Sci U S A. 1970; 67(4):1789-96. PMC: 283428. DOI: 10.1073/pnas.67.4.1789. View

3.
Konig H, Behr E, Lower J, Kurth R . Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma. Antimicrob Agents Chemother. 1989; 33(12):2109-14. PMC: 172830. DOI: 10.1128/AAC.33.12.2109. View

4.
Roberts M, Oroszlan S . The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. Biochem Biophys Res Commun. 1989; 160(2):486-94. DOI: 10.1016/0006-291x(89)92459-5. View

5.
Clavel F, Guyader M, Guetard D, Salle M, Montagnier L, Alizon M . Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature. 1986; 324(6098):691-5. DOI: 10.1038/324691a0. View